These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 30074107
1. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies. Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O. Curr Rheumatol Rep; 2018 Aug 03; 20(9):56. PubMed ID: 30074107 [Abstract] [Full Text] [Related]
2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I. J Neurol Neurosurg Psychiatry; 2016 Oct 03; 87(10):1038-44. PubMed ID: 27147697 [Abstract] [Full Text] [Related]
3. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O. Ann Neurol; 2017 Apr 03; 81(4):538-548. PubMed ID: 28224701 [Abstract] [Full Text] [Related]
4. Peculiar clinicopathological features of immune-mediated necrotizing myopathies. Allenbach Y, Benveniste O. Curr Opin Rheumatol; 2018 Nov 03; 30(6):655-663. PubMed ID: 30239349 [Abstract] [Full Text] [Related]
5. Spectrum of immune-mediated necrotizing myopathies and their treatments. Pinal-Fernandez I, Mammen AL. Curr Opin Rheumatol; 2016 Nov 03; 28(6):619-24. PubMed ID: 27607340 [Abstract] [Full Text] [Related]
6. In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, Jean L, Zoubairi R, Guerout N, Mahler M, Benveniste O, Drouot L, Boyer O. Ann Rheum Dis; 2019 Jan 03; 78(1):131-139. PubMed ID: 30309969 [Abstract] [Full Text] [Related]
7. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L. Ann Rheum Dis; 2017 Apr 03; 76(4):681-687. PubMed ID: 27651398 [Abstract] [Full Text] [Related]
8. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Allenbach Y, Benveniste O, Stenzel W, Boyer O. Nat Rev Rheumatol; 2020 Dec 03; 16(12):689-701. PubMed ID: 33093664 [Abstract] [Full Text] [Related]
9. Immune-Mediated Necrotizing Myopathy. Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Curr Rheumatol Rep; 2018 Mar 26; 20(4):21. PubMed ID: 29582188 [Abstract] [Full Text] [Related]
10. Immune Mediated Necrotizing Myopathy: Where do we Stand? Mohammed AGA, Gcelu A, Moosajee F, Botha S, Kalla AA. Curr Rheumatol Rev; 2019 Mar 26; 15(1):23-26. PubMed ID: 29623846 [Abstract] [Full Text] [Related]
13. Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement. Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W. Neurology; 2018 Feb 06; 90(6):e507-e517. PubMed ID: 29330311 [Abstract] [Full Text] [Related]
14. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. Carvalho AAS, Silva VGD, Vieira TF, Delgado PO, Corazini R, Feder D, Fonseca FLA. Medicine (Baltimore); 2018 Aug 06; 97(35):e11858. PubMed ID: 30170376 [Abstract] [Full Text] [Related]
16. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge. Merlonghi G, Antonini G, Garibaldi M. Autoimmun Rev; 2022 Feb 06; 21(2):102993. PubMed ID: 34798316 [Abstract] [Full Text] [Related]
17. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy. Lia A, Annese T, Fornaro M, Giannini M, D'Abbicco D, Errede M, Lorusso L, Amati A, Tampoia M, Trojano M, Virgintino D, Ribatti D, Serlenga L, Iannone F, Girolamo F. Rheumatology (Oxford); 2022 Aug 03; 61(8):3448-3460. PubMed ID: 34864921 [Abstract] [Full Text] [Related]
18. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies. Matsubara S, Bokuda K, Asano Y, Morishima R, Sugaya K, Miyamoto K, Koide R, Komori T, Suzuki S, Nishino I. Neuromuscul Disord; 2018 Mar 03; 28(3):283-288. PubMed ID: 29402601 [Abstract] [Full Text] [Related]
19. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I. Medicine (Baltimore); 2015 Jan 03; 94(4):e416. PubMed ID: 25634171 [Abstract] [Full Text] [Related]
20. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. Li C, Liu H, Yang L, Liu R, Yin G, Xie Q. J Autoimmun; 2024 Sep 03; 148():103286. PubMed ID: 39033686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]